Valuation: Zynex, Inc.

Market Cap 3.83M 3.28M 3.06M 2.81M 5.27M 366M 5.38M 36.29M 14.15M 184M 14.38M 14.06M 608M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 32.55M 30.37M 27.87M 52.37M 3.64B 53.4M 360M 140M 1.82B 143M 140M 6.04B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months+74.60%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.1
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 17/08/2025
Director of Finance/CFO 50 17/08/2025
General Counsel 53 17/08/2025
Director TitleAgeSince
Director/Board Member 50 25/03/2026
Director/Board Member 53 25/03/2026
Date Insider Type Main position Quantity % Market Cap.
27/07/25 Free

Chief Operating Officer

11,293 0.0355%
05/06/25 Tax

Chief Financial Officer

8,982 0.0282%
15/05/25 Free

Director

10,000 0.0314%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-96.47%-99.28% 1.69M
+2.49%+5.58%+27.15%+18.20% 227B
+3.52%+7.28%+3.47%-12.57% 149B
-5.96%-6.06%-21.54%+31.50% 141B
-4.08%-3.37%-52.90%-0.93% 75.37B
-2.12%-2.59%+10.78%+18.12% 53.19B
-0.43%+1.97%-17.34%-12.47% 51.88B
+1.14%+4.85%+31.42%+31.70% 43.89B
-0.97%-0.42%+38.78%+54.13% 40.86B
-0.14%+0.98%+0.87%+8.04% 33.7B
Average -0.08%-1.06%-7.58%+3.64% 81.49B
Weighted average by Cap. -0.17%+1.31%+2.86%+13.26%

Financials

2023 2024
Net sales 184M 158M 147M 135M 254M 17.64B 259M 1.75B 681M 8.84B 692M 677M 29.26B 192M 165M 154M 141M 265M 18.41B 270M 1.82B 711M 9.22B 722M 707M 30.54B
Net income 9.73M 8.33M 7.77M 7.13M 13.4M 931M 13.67M 92.23M 35.95M 467M 36.54M 35.75M 1.55B 2.99M 2.56M 2.39M 2.19M 4.12M 286M 4.21M 28.37M 11.06M 144M 11.24M 11M 475M
Net Debt 31.59M 27.05M 25.23M 23.16M 43.51M 3.02B 44.37M 299M 117M 1.51B 119M 116M 5.01B 34.19M 29.28M 27.32M 25.06M 47.1M 3.27B 48.02M 324M 126M 1.64B 128M 126M 5.43B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock